objective Tropheryma whipplei, the causative agent of Whipple's disease, can also be identified in stool samples of humans without systemic disease. It is much more frequently detected in human stool samples in tropical environments than in industrialized countries. PCR-screening has been applied for point prevalence studies and environmental assessments in tropical settings, but results depend on the applied assay. We compared one commercial qPCR kit with two well-described inhouse assays for detection of T. whipplei from stool.
Introduction
Whipple's disease is caused by anaerobic rod-shaped Tropheryma whipplei, which was discovered in 1907 by Georg Hoyt Whipple [1] . The systemic infectious disease is characterized by arthritis followed by diarrhea and steatorrhea with severe weight loss but can also be associated with anemia, fever, polyarthritis, spondyloarthropathy, and involvement of the central nervous system [2] [3] [4] [5] . Recent assessments also suggested isolated acute and chronic manifestations of T. whipplei comprising pneumonia, diarrhea, endocarditis, arthritis, uveitis and central nervous system involvement [6] [7] [8] [9] .
Despite a high rate of asymptomatic intestinal colonization, Whipple disease is rare, with a prevalence as low as 3 in 1 000 000 individuals, as published for north-west Italy [10] , suggesting an immunological predisposition of patients.
In Europe, asymptomatic colonization with T. whipplei is infrequent at 1-4% [11, 12] but can reach 12-25% in sewer workers, HIV-infected individuals, or homeless individuals [13] [14] [15] . Stool samples from individuals in resource-limited tropical settings are more frequently positive. In rural Senegal, the prevalence in healthy individuals reaches 31% [16] . Colonization rates reach up to 40% for children in Gabon [17] and of up to 63% within a sub-group of children in South-East Asian Laos [18] . While children <4 years of age were more frequently colonized in Africa [17, 19] , such colonization was preferentially observed in older children in Laos [18] . The clinical relevance of these findings remains a matter of debate.
Precarious hygiene conditions have been presumed to be responsible for high colonization rates in resource-limited tropical countries [17] , with transmission via the fecal-oral route [20] . Transmissions to European travelers returning from the tropics have been documented [21] and a potential association of T. whipplei detection with tropical sprue has been suspected [22] . Environmental investigations to allocate potential sources or animal reservoirs are not available to date. Accordingly, a readily available and reliable test assay would be desirable both for surveillance purposes in resource-limited tropical settings and for environmental screening.
Tropheryma whipplei-specific PCR assays targeting ribosomal RNA genes and intergenic spacer sequences [23] as well as the genes hsp65 [24] , rpoB [25] , and the Dig 15 gene segment [13] have been published. However, specificity has to be evaluated rigorously [26] and published surveillance results seem to depend on the assay used [14] .
Uncertain or even doubtful diagnostic reliability of assays applied for surveillance purposes raises concerns regarding the comparability of study results from surveillance assessments in the tropics. To estimate diagnostic sensitivity and specificity of well-described and frequently used assays for screening purposes in resource-limited high-prevalence settings for colonization with T. whipplei, two in-house real-time qPCR approaches [12, 13, 19, 25] and one commercial qPCR kit were directly evaluated, using a mathematical approach without the need for a diagnostic gold standard.
Methods

Study design and sample materials
As previously described in detail [27] , tests were compared without a gold standard [28, 29] . Anonymous residual nucleic acid extracts from stool samples from routine diagnostics of the Bundeswehr Hospital Hamburg and from the National Reference Centre for Tropical Pathogens Bernhard Nocht Institute for Tropical Medicine Hamburg were assessed. Materials comprised specimens from soldiers and policemen returning from tropical deployments [27, 30, 31] and from study populations from the tropics [19, 32] , so the probability for positive test results for Tropheryma whipplei was considered to be high.
A total of 600 stool samples were assessed-300 from German military and police forces returning from tropical deployments and 300 from a western African high-endemicity region from Ghana. While all German soldiers and policemen were adult, the local Ghanaian population consisted of children between 2 months and 15 years of age [19] . No symptom-dependent selection for samples or patients was performed. This means that all assessed populations have to be regarded as mixed populations concerning medical history of present or recent gastroenteritis.
All stool samples had been collected between 2007 and 2016 for diagnostic procedures and were stored frozen at À80°C.
Nucleic acid extraction
Nucleic acid was extracted using the QiaAMP DNA Stool Mini Kit (Qiagen, Hilden, Germany) as described by the manufacturer for all samples.
PCR protocols
All samples were assessed with three qPCR tests, including one commercial kit. Internal control testing was included for economical reasons only with the kit (subsequently referred to as PCR 3).
The first assay (PCR 1) is a FRET probe based assay targeting the rpoB gene as described by Moter et al. [25] ( Table 1 ) on a LightCycler 2.0 Instrument (Roche Diagnostics, Mannheim, Germany). Samples were accepted as positive only in the case of a melting peak with a T m (melting temperature) of 63°C AE 1°C [25] . A plasmidbased positive control (pEX-A128 vector backbone, Eurofins Scientific SE, Luxembourg) was used ( Table 1) .
The second assay (PCR 2) consists of two published qPCR assays (referred to as PCR 2.1 and 2.2) targeting Dig 15 [13, 19] performed on a Corbett Rotor-Gene 6000 or Rotor-Gene Q (Qiagen, Hilden, Germany) with minor adaptations as follows: 20 ll reaction volume contained 10 ll HotStar master mix (Qiagen), 8 mM MgCl 2 , 250 nM primer, 50 nM of the respective probes, and 2 ll DNA eluate. The running scheme was as follows: activation at 95°C for 15 min (minutes), 40 cycles of 5 s (seconds) denaturation at 95°C followed by 60 s annealing and elongation at 60°C. Again, the positive control was a recombinant plasmid (pEX-A128 vector backbone, Eurofins Scientific SE) ( Table 1) . Although PCR 2.2 was originally designed for quantification purposes [13] it was applied as a qualitative test. PCR2 was considered as positive only if both PCR 2.1 and PCR 2.2 showed positive results.
The commercial kit (PCR 3) was a duplex assay of LightMix Modular T. whipplei (Cat. No. 53-0606-96) amended by a PhHV-(Phocid Herpes virus)-based control reaction (66-06250-96) from Tib MolBiol (Berlin, Germany). The test was done following the instructions for use but utilizing a Rotor-Gene instrument. Positive controls were provided with the kits.
Positive (with cycle threshold (C t ) values) and negative results were documented for all samples and tests.
Statistical assessment
Estimation of theoretical, not clinically verified sensitivity and specificity for PCR2.1 and PCR2.2 was done applying the approach of Hui and Walter (see Appendix S1).
For PCR1 as well as PCR3, sensitivity and specificity were assessed with the approach of Gart and Buck (see Appendix S1) using PCR2.1 as reference test.
Agreement between the three qPCR tests (kappa) was calculated using the software Stata/IC 14.1 for Mac 64-bit Intel (College Station, TX, USA). Categories were Table 1 Primers and probes of the in-house qPCR assays 1 and 2. The table also lists oligonucleotide concentrations, insert sequences of the positive control plasmids, and the minimum detectable genomic equivalents as assessed with positive control plasmids under the applied cycling conditions. The software "Scienceprimer" (http://scienceprimer.com/copy-number-calculator-for-realtime-pcr, last accessed on 28 May 2018) was applied for the calculation of assessed genomic equivalents qPCR approach 
Ethical clearance
Ethical clearance for the blinded use of residual materials for test comparison and evaluation purposes was provided by the ethics committee of the Medical Association of Hamburg, Germany (registration number WF-043/16) in line with national laws.
Results
Performance of the qPCR assays
The calculated theoretical sensitivity and specificity values are detailed in Table 2 , showing best sensitivity for PCR2 with 86%, followed by PCR3 with 68% and PCR1 with 48%. For both PCR1 and PCR2, specificities of 100% were calculated, while the specificity of PCR3 was 97%. Sample inhibition was detected for 1 sample from the western African study group (group 1) and 11 samples from the group of soldiers and policemen (group 2) when applying PCR 3. For PCR 3; these inhibited samples were not counted as negative and were excluded from further calculations. Of note, one of the inhibited samples from PCR3 was positive in both other assays. For the two inhouse assays, no information on PCR-specific sample inhibition was available, so all 300 samples per group were assessed. If assessed without combined use, sensitivity and specificity of PCR2.1 would be 100% and 100%, and for PCR2.2 the values would be 85% and 96%, respectively.
Substantial agreement [33] between the three compared qPCR assays was observed (Table 2) . Nevertheless, the different assays gave surprisingly different fractions of positive results for both study groups: For study participants from group 1 and group 2, the proportions of positive samples were 14.7% (44/300) and 1.5% (4/300) for PCR1, while they were 24.3% (73/300) and 4.3% (13/ 300) for PCR 2, as well as 18.1% (54/299) and 10.0% (29/289) for PCR 3, respectively. For PCR 2.1 and 2.2, the respective numbers were 28.3% (85/300) and 5.0% (15/300) as well as 26.7% (80/300) and 7.3% (22/300). Considering the calculated test characteristics (Table 2 ), a prevalence of 28.3% for group 1 and of 5.0% for group 2 was estimated.
Assessment of C t values
A PCR-target-specific pattern was observed for the distribution of strongly positive, positive, and weakly positive specimens as defined by positive test results in three, two, or one assay, respectively (Table 3) .Thereby, PCR3 resulted in the highest number of weakly positive samples, followed by PCR 2 and PCR 1. In turn, PCR2 yielded the highest number of positive results followed by PCR 3 and PCR 1. In detail, 40 samples tested positive in all three assays, while 14 weakly positive samples were observed for PCR2 only and 19 additional ones for PCR3. From 7 positives in PCR1, 7 were also detected by PCR2 and 0 by PCR3; from 31 positives in PCR2, 7 were also detected by PCR1 and 24 by PCR3; and from 24 positives in PCR3, 0 were also detected by PCR1 and 24 by PCR2.
The mean of measured C t values did not correlate with the number of positive or weakly positive samples (Table 4) , because the mean values from all three assays were of a comparable magnitude. However, this correlation was obvious for the strongly positive samples.
Discussion
This study compared two published qPCR assays and one commercial kit regarding their detection rate for T. whipplei in stool samples for surveillance testing in high-prevalence settings. Under those conditions, calculated sensitivity and specificity values suggest highest reliability of PCR 2, followed by PCR3, and lastly PCR1. However, the data did not indicate that results from PCR 2.1 and 2.2 had to be combined for a consistent interpretation. On the contrary, the combination of PCR 2.1 and PCR 2.2 considerably reduced sensitivity and left specificity unchanged, while use of the screening PCR2.1 alone was associated with highest sensitivity and specificity of 100% each. The observed agreement between the three assays was substantial [33] . Discordant positive results while comparing the assays could be due to different sensitivity combined with low copy-numbers of the target genes in the assessed samples. Interestingly, there was no obvious association between discrepant results in the three assays and very high C t values resulting from extremely low quantities of target DNA. On the contrary, "positive" samples and "weakly positive" samples showed comparable C t values. For high amounts of specific target DNA and consequently low C t values such as were observed in the group of "strongly positive" samples, however, the three tests displayed highly concordant results.
As described by Rogan and Gladen [34] , diagnostic accuracy-adjusted methods can be used for calculation of prevalence and incidence in point-prevalence and surveillance assessments. Without such calculations, however, surveillance data have to be interpreted with care due to the observed differences in the calculated test characteristics.
As a side effect of the study, it was shown that the prevalence of T. whipplei in stool samples of German soldiers and policemen returning from tropical deployments is in the range of 5% and thus similar to the average European population with 1-4% [11, 12] . Considering the low probability of progression to Whipple's disease, with only three cases per 1 000 000 inhabitants in Southern European Italy [10] and an immunological predisposition being necessary to develop Whipple's disease, screening of returnees cannot be used to identify individuals who may develop the disease.
A prevalence of colonization with T. whipplei of about 28.3% was estimated for the young tropical population assessed here. This finding is a nearly perfect match with the results of the previous study [19] , underlining the validity of the results and the calculations.
The major limitation of the study is the lack of control groups of individuals who are definitely colonized or notcolonized with T. whipplei. Due to the retrospective approach, this cannot be resolved. Another limitation is the lack of correlation with clinical symptoms, which would have been beyond the scope of this mathematical (2) 31 (5) 40 (7) 85 (14)* PCR 3
19 (3) 24 (4) 40 (7) 83 (14) *The total numbers of positive results in PCR 2.1 and PCR2.2 were 99 (17%) and 101 (17%), respectively. Only results that were positive in PCR2.1 and PCR2.2 are shown in the table. (27, 36) Weakly positive = 1 out of 3 qPCR platforms positive. Positive = 2 out of 3 qPCR platforms positive. Strongly positive = 3 out of 3 qPCR platforms positive.
modeling-based approach. Of note, only one case report of Whipple's disease in Africa has been published [35] . Association of T. whipplei with diarrhea has been suggested by multiple studies [36] [37] [38] , although contradicting results have been described as well [19] . For financial reasons, discrepant results were not resolved by sequencing or other methods. This is also why the study did not include internal inhibition controls in PCR1 and PCR2, potentially leading to false negative results. Furthermore, there was no proof of specificity of PCR3 using a panel of related bacterial strains, so the assay relies only on insilico assessments and the applied mathematical modeling.
In addition, each indirect estimation of sensitivity and specificity is necessarily prone to bias depending on how well the prerequisites for the applied mathematical models are fulfilled. In particular for PCR 1 and to a lesser degree for PCR 2, varying sensitivity for the different assessed study populations has to be considered. As a likely reason, low copy numbers in the infrequently colonized low-prevalence group [13] of deployed soldiers and policemen may be of relevance. Further, the storage of samples at À0°C may affect the detection rate due to DNA fragmentation, since PCR1 and PCR2 amplify longer DNA fragments [13, 25] . Because of these facts, a potential bias of the estimation cannot be excluded and the method of Hui & Walter [29] has not been used for the estimation of the test characteristics of PCR1 and PCR3 for this reason. The main statements above on the potential usefulness of the approaches nevertheless remain unaffected by such potential bias.
Lastly, on a level of higher abstraction, the applied mathematical algorithms do not estimate the true abundance of T. whipplei but only the combined abundance of the three PCR targets rpoB, Dig 15, and the multicopy-target from the commercial kit in the same sample. They confirm neither that the hypothetical target organism is indeed T. whipplei nor that the PCR targets of all three assays are abundant in T. whipplei only. If individual PCR targets occur in other, phylogenetically related microorganisms within the assessed samples with an identical sequence as well, the resulting bias cannot be mathematically resolved without specific knowledge of the proportions of abundance of the target gene in T. whipplei and non-target species within the samples. Therefore, the applied models allow only a relative comparison of the reliability of the three assays only without definite certainty on their true target, a problem that results from the different genetic targets of the three qPCR assays and cannot be overcome in the absence of a gold standard. It has to be stressed that assays with thorough evaluation against non-PCR-based gold standards like PCR1 [25] should not be undervalued simply because of apparently lower sensitivity in the assessment presented here. Finally, the screening approaches do not provide any information on association with Whipple's disease but just hints about enteric colonization.
Nevertheless, aim of this study was to compare the performance of the three assays for the purpose of detection of T. whipplei for surveillance and environmental studies to elucidate the transmission of the bacterium. While PCR2.1 showed excellent sensitivity for such assessments from stool samples, the commercial kit was most easy to perform and is ready to hand for larger studies. Our study did not analyze PCR performance for diagnostic use, as we did not evaluate specificity and sensitivity in practical use and with clinical samples. For diagnosis of Whipple's disease, invasive sampling and a positive result with two different PCR targets, as well as histological and clinical evidence, is mandatory. However, sensitive PCR has the potential to improve diagnostics with focus on detection of residual disease and therapy control. Prospective studies will be necessary to evaluate the performance of this promising approach.
Conclusions
The study suggests differences in the performance of the tests that have to be considered when results of point-prevalence or surveillance assessments of T. whipplei are interpreted. If diagnostic accuracy-adjusted methods [34] are applied, however, cost-efficient in-house multiplex real-time qPCR approaches can also be used for surveillance purposes.
